Literature DB >> 9377538

Self-monitoring cognitive performance during sleep deprivation: effects of modafinil, d-amphetamine and placebo.

J V Baranski1, R A Pigeau.   

Abstract

Self-monitoring refers to the ability to assess accurately one's own performance in a specific environment. The present study investigated the effects of the stimulating drugs modafinil (300 mg) and d-amphetamine (20 mg) on the ability to self-monitor cognitive performance during 64 h of sleep deprivation (SD) and sustained mental work. Two cognitive tasks were investigated: a visual (perceptual) judgement task and a complex mental addition task. Subjects in the placebo condition displayed marked circadian and SD effects on cognitive task performance but their self-monitoring was substantively undisturbed by SD. Subjects performing under the influence of d-amphetamine likewise displayed highly proficient self-monitoring throughout the SD period. In contrast, modafinil had a disruptive effect on self-monitoring, inducing a reliable 'overconfidence' effect (i.e. an overestimation of actual cognitive performance), which was particularly marked 2-4 h post-dose. Although modafinil has proven to be a safe and effective countermeasure to the effects of extensive SD on cognitive task performance, we encourage a more comprehensive understanding of the relation between its subjective and performance enhancing effects before the drug is recommended as a viable fatigue countermeasure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9377538     DOI: 10.1111/j.1365-2869.1997.00032.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  17 in total

1.  Suppression of hippocampal cell proliferation by short-term stimulant drug administration in adult rats.

Authors:  Linda J Kochman; Casimir A Fornal; Barry L Jacobs
Journal:  Eur J Neurosci       Date:  2009-06-01       Impact factor: 3.386

2.  Fatigue, countermeasures, and performance enhancement in resident physicians.

Authors:  Steven H Rose; Timothy B Curry
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

Review 3.  Sleep, circadian rhythms and health.

Authors:  Russell G Foster
Journal:  Interface Focus       Date:  2020-04-17       Impact factor: 3.906

4.  Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.

Authors:  K J McClellan; C M Spencer
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

5.  Methamphetamine attenuates disruptions in performance and mood during simulated night-shift work.

Authors:  Carl L Hart; Amie S Ward; Margaret Haney; Jennifer Nasser; Richard W Foltin
Journal:  Psychopharmacology (Berl)       Date:  2003-05-07       Impact factor: 4.530

6.  Methamphetamine self-administration by humans subjected to abrupt shift and sleep schedule changes.

Authors:  Matthew G Kirkpatrick; Margaret Haney; Suzanne K Vosburg; Sandra D Comer; Richard W Foltin; Carl L Hart
Journal:  Psychopharmacology (Berl)       Date:  2008-12-04       Impact factor: 4.530

Review 7.  Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review.

Authors:  Kara Simone Bagot; Yifrah Kaminer
Journal:  Addiction       Date:  2014-04       Impact factor: 6.526

8.  Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG.

Authors:  Florian Chapotot; Ross Pigeau; Frédéric Canini; Lionel Bourdon; Alain Buguet
Journal:  Psychopharmacology (Berl)       Date:  2003-01-28       Impact factor: 4.530

9.  Effects of modafinil on working memory processes in humans.

Authors:  Ulrich Müller; Nikolai Steffenhagen; Ralf Regenthal; Peter Bublak
Journal:  Psychopharmacology (Berl)       Date:  2004-06-24       Impact factor: 4.530

10.  Effects of total sleep deprivation on the perception of action capabilities.

Authors:  Yannick Daviaux; Jean-Baptiste Mignardot; Christophe Cornu; Thibault Deschamps
Journal:  Exp Brain Res       Date:  2014-04-02       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.